Biocon launches Liraglutide injection (Diavorin & Vobexoryn) for diabetes and weight management in the Netherlands with ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, ...

Biocon Ltd on Monday said it has launched its diabetes and chronic, Liraglutide, in the Netherlands through its distribution partner, Pharmamedic BV.   The drug-device combination will be marketed in ...

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...

New trial finds liraglutide reduces brain shrinkage by nearly 50% in Alzheimer’s patients and slows cognitive decline by up to 18% ...

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

Bynes has been vocal about her weight-loss journey, which began in June with the trendy GLP-1 agonist drug Ozempic so she ...

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable ...

For Immediate Release Chicago, IL – December 9, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent ...

The European Medicines Agency's committee on Friday recommended extending the use of Eli Lilly's blockbuster drug Mounjaro for the treatment of type 2 diabetes in adolescents and ...